Cytosorbents (CTSO) Net Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Cytosorbents (CTSO) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -641.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 420.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 484.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 459.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 941.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -1,024.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 574.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 300.00 |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 1,946.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,946.00 |
| Mar 31, 2026 | 1,966.00 |
| Dec 31, 2025 | -5,137.00 |
| Sep 30, 2025 | 11,700.00 |
| Jun 30, 2025 | 14,830.00 |
| Mar 31, 2025 | 8,622.00 |
| Dec 31, 2024 | 363.00 |
| Sep 30, 2024 | 3,350.00 |
| Jun 30, 2024 | -966.00 |
| Mar 31, 2024 | -3,140.00 |
| Dec 31, 2023 | -6,165.00 |
| Sep 30, 2023 | -9,638.00 |
| Jun 30, 2023 | -3,604.00 |
| Mar 31, 2023 | -3,787.00 |
| Dec 31, 2022 | 4,499.00 |
| Sep 30, 2022 | -3,745.00 |
| Jun 30, 2022 | -7,114.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | 254.00 |
| Sep 30, 2021 | -1,331.00 |